Literature DB >> 7763058

Otoacoustic emissions as a screening test for hearing impairment in children.

M P Richardson1, T J Williamson, S W Lenton, M J Tarlow, P T Rudd.   

Abstract

Transient evoked otoacoustic emissions (TEOAEs) are low amplitude sound waves produced by the healthy cochlea. They can be recorded with a microphone in the external ear. TEOAEs are abolished by hearing losses of 30 dB or more. The feasibility of using TEOAEs as a screening test for hearing loss in children was studied. TEOAE recordings were attempted in 56 children attending an audiology clinic. Recordings were possible from both ears in 52 children; of these 104 ears, 32 had hearing deficits of 30 dB or more. Hearing status was compared with the results of six TEOAE screening criteria. All criteria had a sensitivity of 1.00. Four standard TEOAE criteria yielded specificities of 0.46-0.58. Two new criteria derived from analysis of limited frequencies from the TEOAE waveform gave specificities of 0.76 and 0.82. It can be concluded that, when appropriate pass/fail criteria are employed, TEOAEs are a feasible screening test in children.

Entities:  

Mesh:

Year:  1995        PMID: 7763058      PMCID: PMC1511251          DOI: 10.1136/adc.72.4.294

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Screening infants for hearing loss.

Authors:  J Brown; E Watson; E Alberman
Journal:  Arch Dis Child       Date:  1989-10       Impact factor: 3.791

2.  Otoacoustic emissions and auditory brainstem responses in the newborn.

Authors:  C R Kennedy; L Kimm; D C Dees; P I Evans; M Hunter; S Lenton; R D Thornton
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

3.  Click evoked otoacoustic emissions compared with brain stem electric response.

Authors:  J C Stevens; H D Webb; J Hutchinson; J Connell; M F Smith; J T Buffin
Journal:  Arch Dis Child       Date:  1989-08       Impact factor: 3.791

4.  A guide to the effective use of otoacoustic emissions.

Authors:  D T Kemp; S Ryan; P Bray
Journal:  Ear Hear       Date:  1990-04       Impact factor: 3.570

5.  Acoustic emission cochleography--practical aspects.

Authors:  D T Kemp; P Bray; L Alexander; A M Brown
Journal:  Scand Audiol Suppl       Date:  1986

6.  Confirmation of transiently evoked otoacoustic emissions based on user-independent criteria.

Authors:  K Welzl-Müller; K Stephan
Journal:  Audiology       Date:  1994 Jan-Feb

7.  Evoked acoustic emissions from the human ear. III. Findings in neonates.

Authors:  N J Johnsen; P Bagi; C Elberling
Journal:  Scand Audiol       Date:  1983

8.  Stimulated acoustic emissions from within the human auditory system.

Authors:  D T Kemp
Journal:  J Acoust Soc Am       Date:  1978-11       Impact factor: 1.840

9.  The clinical application of oto-acoustic emissions in paediatric audiological assessment.

Authors:  M Baldwin; P Watkin
Journal:  J Laryngol Otol       Date:  1992-04       Impact factor: 1.469

10.  An advanced cochlear echo technique suitable for infant screening.

Authors:  P Bray; D Kemp
Journal:  Br J Audiol       Date:  1987-08
View more
  5 in total

1.  Unseen blindness, unheard deafness, and unrecorded death and disability: congenital rubella in Kumasi, Ghana.

Authors:  J E Lawn; S Reef; B Baffoe-Bonnie; S Adadevoh; E O Caul; G E Griffin
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

2.  Neonatal otoacoustic emission screening and the identification of deafness.

Authors:  P M Watkin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

3.  Transient evoked otoacoustic emissions.

Authors:  Ravi Kapoor; Naresh K Panda
Journal:  Indian J Pediatr       Date:  2006-04       Impact factor: 1.967

Review 4.  Otoacoustic emissions.

Authors:  M Richardson
Journal:  Arch Dis Child       Date:  1995-10       Impact factor: 3.791

5.  Hearing loss during bacterial meningitis.

Authors:  M P Richardson; A Reid; M J Tarlow; P T Rudd
Journal:  Arch Dis Child       Date:  1997-02       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.